Douwe Postma

Dr. Douwe Postma is a Clinical Professor at the Faculty of Medical Sciences, University of Groningen. His research focuses on Infectious Diseases and Clinical Epidemiology, with expertise in fungal infections, clinical trial methodologies, and public health interventions. He actively contributes to improving data reporting standards in clinical research and has collaborated on studies addressing critical issues like mortality prediction in hospitalized patients with COVID-19 and the efficacy of vaccine boosters against viral variants.

His work spans multiple disciplines, including immunology, pulmonary medicine, and critical care, with a particular emphasis on immunocompromised patients and fungal infections. Postma has also engaged in public discourse on vaccine strategies and resistance mechanisms, as evidenced by his expert commentary in media outlets.

Recent research highlights include groundbreaking studies on lung transplantation outcomes, the impact of bivalent vaccines against Omicron subvariants, and the development of novel informed consent frameworks for clinical trials. Despite no explicitly listed students, he collaborates extensively with researchers globally, as seen in his multi-authored publications.